Matthew Matasar, MD, is the chief of blood disorders at Rutgers Cancer Institute.
Global Hematology Experts Reflect on Key Takeaways From the EHA 2025 Congress
June 16th 2025At the 30th European Hematology Association (EHA) Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.